Petrolatum and Mineral Oil in Cosmetics: The Same Substance, Two Different Cancer Classifications

Georden Jones, Founder, The Peer Review · Last updated: August 29, 2026

---

The Short Answer

Petrolatum and mineral oil are petroleum byproducts refined for use as moisturizing, occlusive ingredients in lip balm, lotion, ointment, and baby products, and this is one of the clearest cases on this site where the degree of processing, not the base material, determines the actual hazard. The International Agency for Research on Cancer draws a sharp, explicit line between two versions of essentially the same substance: untreated and mildly treated mineral oils are classified as Group 1, a known human carcinogen, based on decades of strong, consistent evidence linking occupational exposure to skin cancer, while highly refined mineral oils, the kind purified to remove contaminating polycyclic aromatic hydrocarbons, are classified as Group 3, not classifiable as to carcinogenicity, because the refining process removes the contaminants responsible for the Group 1 finding [1][2]. The contaminants at the center of this distinction are polycyclic aromatic hydrocarbons, a class of compounds the US National Toxicology Program considers reasonably anticipated human carcinogens, and pharmaceutical-grade petrolatum meeting the USP purity standard is refined to below 2 parts per million PAH content, effectively removing them to below detectable levels [1][3]. The regulatory gap between jurisdictions is unusually direct here: the European Union requires cosmetic manufacturers to document the full refining history of any petrolatum or mineral oil ingredient and prove the source material is not carcinogenic, or the ingredient is simply prohibited, while the United States imposes no such documentation requirement on cosmetic-grade petrolatum at all [3][4].

Evidence Rating: Mixed Signals. Untreated and mildly refined mineral oil causing skin cancer through occupational exposure is General Consensus, formally established by IARC’s Group 1 classification and decades of consistent occupational epidemiology [1]. Highly refined, PAH-depleted petrolatum and mineral oil, the kind used in properly documented cosmetic products, carries no confirmed human carcinogenicity evidence and sits in IARC’s not-classifiable category [1][2]. The open risk is not about the chemistry of petrolatum itself. It is about whether a specific product was refined to the standard that actually removes the hazard, a question the EU forces manufacturers to answer with documentation and the US does not ask at all.

---

Table of Contents

• Identify: Why the Same Ingredient Gets Two Different Classifications
• Where It Hides
• How It Affects You and Enters the Body
• Investigate: The Refining Distinction, Explained
• What Canada Regulates, and What It Does Not
• What Canada, the US, and the EU Require
• Inform: What This Means for You
• Improve: How to Reduce Risk Without Overreacting
• What This Does Not Mean
• FAQ
• The Bottom Line
• References

---

Identify: Why the Same Ingredient Gets Two Different Classifications

Petrolatum, also called petroleum jelly, and mineral oil are both derived from crude petroleum through distillation and refining. In their crude or lightly processed form, they carry residual polycyclic aromatic hydrocarbons, a large family of compounds formed during the incomplete combustion or processing of organic material, several of which IARC and the NTP recognize as probable or known human carcinogens [1][3]. Refining removes these contaminants. The more thorough the refining process, using techniques like solvent extraction, hydrotreatment, and vacuum distillation, the lower the residual PAH content, and pharmaceutical-grade petrolatum meeting the United States Pharmacopeia standard is purified to below 2 parts per million, a level low enough that IARC’s own evaluation places highly refined mineral oils in a completely different, non-classifiable hazard category from the untreated version [1][3].

This is not a marginal technical distinction. It is the entire basis for how regulators approach this ingredient family. A manufacturer using properly refined, pharmaceutical-grade petrolatum is working with a substance that has no confirmed human carcinogenicity evidence behind it. A manufacturer using a poorly refined, undocumented, cheaper source material is potentially working with a substance IARC has formally classified as a known human carcinogen. The finished lip balm or lotion on a store shelf gives you no visual way to tell which one you are holding.

---

Where It Hides

Petrolatum and mineral oil appear across an enormous share of everyday personal care and household products, both cosmetic and medicinal [1][3][5]:

• Lip balm and lip care products. One of the highest-exposure categories, since lip products are applied directly to a mucous membrane and partially ingested through normal use.
• Baby lotion, baby oil, and diaper cream. A particularly sensitive-population use case, since infant skin is thinner and more permeable than adult skin.
• Moisturizers, body lotion, and hand cream. Valued for its occlusive, moisture-locking properties on dry or damaged skin.
• Ointments and wound-care products. Petroleum jelly’s classic medicinal use, where the USP pharmaceutical-grade purity standard applies most rigorously.
• Makeup removers, cleansing balms, and some foundation or concealer formulas. Mineral oil is a common carrier and emollient in these product types.
• Hair pomade, styling wax, and shine serums. Used for its slick, smoothing texture.

---

How It Affects You and Enters the Body

The exposure pathway for petrolatum and mineral oil is straightforward, but the risk it carries depends entirely on the contaminant load of the specific product, not on a universal property of the ingredient itself [1][3]:

• Direct skin contact and absorption is the primary route, since these products are applied topically as moisturizers, ointments, and lip care. Petrolatum itself forms an occlusive barrier rather than being significantly absorbed, but any PAH contaminants present in a poorly refined batch can be absorbed along with incidental transfer during use [1].
• Lip products introduce a partial ingestion route that other applications do not. Because lip balm sits on a mucous membrane that also functions as part of the digestive entry point, a meaningful fraction of any product applied to the lips over a day is swallowed, which raises the stakes specifically for PAH contamination in this product category compared to a body lotion applied to intact skin [5].
• Historical occupational exposure, the source of the Group 1 classification, came through prolonged, repeated skin contact with untreated industrial oils, in occupations like metal machining and textile processing, not through consumer cosmetic use, which is an important distinction covered in more depth in the Investigate section below [1][2].
• Inhalation is not a significant route for typical cosmetic use of petrolatum or mineral oil products.

---

Investigate: The Refining Distinction, Explained

1. Untreated and mildly treated mineral oils and occupational skin cancer (strong, established evidence). IARC’s Group 1 classification for untreated and mildly treated mineral oils rests on strong, consistent evidence from occupations with prolonged skin contact to industrial-grade oils, particularly metal machining, mulespinning in textile production, and jute processing, where workers showed a clear, repeated association with squamous-cell skin cancers, notably including scrotal cancer, one of the original occupational cancers identified in the history of oncology [1][2]. Animal studies reinforced this finding directly: repeated skin application of vacuum-distillate fractions, acid-treated oils, and mildly refined solvent- or hydrotreated oils produced skin tumors in mice [1].

2. Highly refined mineral oils and petrolatum (no confirmed human carcinogenicity evidence). As refining technology improved, manufacturers developed processes, solvent extraction, hydrotreatment, and vacuum distillation among them, that remove the polycyclic aromatic hydrocarbons responsible for the Group 1 finding. IARC’s own evaluation reflects this directly, placing highly refined mineral oils in Group 3, not classifiable as to carcinogenicity to humans, a category reserved for substances where the evidence does not support a hazard classification either way [1][2]. Germany’s federal risk assessment institute reviewed the specific question of cosmetic use and concluded that health risks are not expected from highly refined mineral oils used under current European regulatory conditions, precisely because those conditions require the refining history to be documented and proven [3].

3. The open variable is refining quality and documentation, not the base chemistry. This is what determines the risk for a specific product on a specific shelf. A product made with pharmaceutical-grade, USP-standard petrolatum, refined below 2 parts per million PAH content, carries essentially none of the hazard behind the Group 1 classification [1][3]. A product made with a less rigorously refined, undocumented source, which is legal to sell in markets that do not require refining history disclosure, could plausibly carry meaningfully higher PAH content, though without published cosmetic-market testing data specific to this scenario, the honest answer is that consumers in undocumented-refining markets are relying on manufacturer practice rather than a verified regulatory floor [3][4].

---

What Canada Regulates, and What It Does Not

Health Canada does not maintain a specific, published PAH concentration limit or mandatory refining documentation requirement for petrolatum or mineral oil used in cosmetics. Instead, Canada relies on its general cosmetic safety framework, which places the burden on manufacturers to ensure their ingredients and finished products are safe as formulated and used, without a petrolatum-specific testing or disclosure mandate comparable to the EU’s [4]. Health Canada notes that, as of its most recent public guidance, there have been no reports of unacceptable PAH impurities identified in petrolatum used in products regulated in Canada, though this reflects an absence of reported problems within a system that does not require the kind of proactive documentation the EU mandates, not the outcome of a dedicated testing program [4].

This puts Canada in a middle position: not silent on the ingredient the way the US federal system is, since general safety obligations do technically apply, but without the specific, verifiable refining-history requirement that gives the EU’s approach its teeth.

---

What Canada, the US, and the EU Require

Requirement	Canada	United States	European Union
Refining history documentation for cosmetic petrolatum/mineral oil	Not specifically required; general product safety obligation applies [4]	Not required for cosmetics [3][4]	Required; full refining history must be known and proven non-carcinogenic, or the ingredient is prohibited [3][4]
PAH testing standard	No published cosmetic-specific PAH limit	No mandatory limit; USP pharmaceutical-grade standard (under 2 ppm) exists but is voluntary for cosmetic use [3]	IP346 test method accepted as an alternative to full documented refining history [3]
Consequence of undocumented refining	No specific consequence beyond general safety obligation [4]	No specific consequence [3][4]	Ingredient is prohibited from use in cosmetics if refining history cannot be established [3][4]
Reported contamination incidents	None reported as of most recent Health Canada guidance [4]	Not systematically tracked at the federal cosmetic level	EU’s mandatory documentation approach designed specifically to prevent this exposure from occurring

The EU stands apart from both North American regulators here in a way that is unusually clean-cut compared to most ingredients covered on this site. Rather than setting a numeric limit and hoping manufacturers comply, the EU shifted the entire burden of proof onto the manufacturer: no documented refining history, no market access. Canada and the US both rely on a general safety framework that assumes compliance rather than requiring proof of it upfront.

---

Inform: What This Means for You

• The cancer classification difference between untreated and highly refined mineral oil is not a marketing distinction. It is IARC’s own formal, two-tier classification, Group 1 for one, Group 3 for the other, based on the same underlying evaluation process [1][2].
• PAH contamination, not petrolatum itself, is the actual hazard, and refining is what removes it. A properly refined product and a poorly refined one can carry the same INCI ingredient name while presenting genuinely different risk profiles [1][3].
• The EU is the only one of the three jurisdictions that requires manufacturers to prove their refining process removed the hazard before the product can be sold. Canada and the US both rely on manufacturers to self-police this [3][4].
• Lip products carry a distinct consideration beyond skin-applied products, because partial ingestion during normal use raises the stakes of any PAH contamination specifically for this product category [5].
• Pharmaceutical-grade, USP-standard petrolatum is a real, verifiable purity benchmark you can look for, refined to below 2 parts per million PAH content, effectively below the level associated with the Group 1 hazard [1][3].

---

Improve: How to Reduce Risk Without Overreacting

1. Look for “USP” or “pharmaceutical grade” on petrolatum-based products, especially lip balm, since this is a real, verifiable purity standard tied to documented PAH testing, not a vague marketing claim [1][3].
2. Prioritize this concern for lip products over body lotion or hand cream, given the partial ingestion pathway unique to products applied to the lips [5].
3. Products formulated to comply with EU cosmetics regulation have already had their refining history documented and verified, which is a useful shortcut if a brand sells the same formula in both the EU and North American markets.
4. Do not assume “petroleum-derived” alone means hazardous. The refining process, not the crude source material, determines whether the Group 1 hazard is actually present in a finished product [1][2].
5. If a brand cannot or will not disclose whether its petrolatum meets a recognized purity standard, that absence of information is itself useful data, particularly given that the US imposes no requirement to disclose it at all [3][4].

---

What This Does Not Mean

This is not a case for treating every jar of petroleum jelly as a hidden carcinogen, and it is not a case for dismissing the underlying hazard because most modern cosmetic petrolatum is well refined. IARC’s Group 1 classification for untreated and mildly treated mineral oil is a real, well-established finding backed by decades of consistent occupational cancer evidence, and it is not erased by the existence of a separate, better-refined version of the same base material. At the same time, highly refined, pharmaceutical-grade petrolatum carries no confirmed human carcinogenicity evidence, and the European risk assessment institute that reviewed this specific question concluded health risks are not expected under proper refining conditions. The accurate picture requires holding both facts together: the hazard is real for poorly refined material, the modern purified version used in most reputable cosmetic products has a genuinely different risk profile, and the honest gap in consumer protection is not about the chemistry, it is about the fact that the US does not require manufacturers to prove which version you are actually getting.

---

FAQ

---

The Bottom Line

Petrolatum and mineral oil illustrate one of the clearest refining-dependent hazards covered on this site. IARC formally classifies untreated and mildly treated mineral oil as a known human carcinogen based on decades of occupational skin cancer evidence, while placing highly refined mineral oil, the kind purified to remove the responsible polycyclic aromatic hydrocarbon contaminants, in its not-classifiable category entirely [1][2]. The European Union requires manufacturers to document and prove their refining process before a petrolatum-based ingredient can be sold in cosmetics, while the United States imposes no equivalent requirement, and Canada relies on a general safety obligation without a petrolatum-specific documentation mandate [3][4]. The practical answer is not to avoid this ingredient family altogether. It is to look specifically for pharmaceutical-grade, USP-standard petrolatum, a real and verifiable purity benchmark, particularly in lip products where partial ingestion raises the stakes of contamination.

Stay curious, stay critical.
Georden

---

References

1. IARC. “Mineral Oils: Untreated and Mildly-Treated Oils and Highly-Refined Oils,” Overall Evaluations of Carcinogenicity.
2. National Toxicology Program. “Mineral Oils: Untreated and Mildly Treated,” 15th Report on Carcinogens.
3. German Federal Institute for Risk Assessment (BfR). “Highly Refined Mineral Oils in Cosmetics: Health Risks Are Not to Be Expected According to Current Knowledge.”
4. Health Canada. “Safety of Cosmetic Ingredients.”
5. Safe Cosmetics. “Petrolatum, Petroleum Jelly.”

---

Georden Jones is the founder of The Peer Review. Read the full story.